[HTML][HTML] Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
E Carnero Contentti, J Correale - Journal of Neuroinflammation, 2021 - Springer
Neuromyelitis optica (NMO) is a chronic inflammatory autoimmune disease of the central
nervous system (CNS) characterized by acute optic neuritis (ON) and transverse myelitis …
nervous system (CNS) characterized by acute optic neuritis (ON) and transverse myelitis …
[HTML][HTML] Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide
JY Hor, N Asgari, I Nakashima, SA Broadley… - Frontiers in …, 2020 - frontiersin.org
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease of
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …
[HTML][HTML] MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
J Sastre-Garriga, D Pareto, M Battaglini… - Nature Reviews …, 2020 - nature.com
Early evaluation of treatment response and prediction of disease evolution are key issues in
the management of people with multiple sclerosis (MS). In the past 20 years, MRI has …
the management of people with multiple sclerosis (MS). In the past 20 years, MRI has …
[HTML][HTML] Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms
Iron is an essential micronutrient that is problematic for biological systems since it is toxic as
it generates free radicals by interconverting between ferrous (Fe 2+) and ferric (Fe 3+) forms …
it generates free radicals by interconverting between ferrous (Fe 2+) and ferric (Fe 3+) forms …
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
M Watanabe, Y Nakamura, Z Michalak, N Isobe… - Neurology, 2019 - AAN Enterprises
Objective To test the hypothesis that serum levels of glial fibrillary acidic protein (GFAP) and
neurofilament light chain (NfL), which are an intermediate astrocyte and neuron filaments …
neurofilament light chain (NfL), which are an intermediate astrocyte and neuron filaments …
[HTML][HTML] The air we breathe: air pollution as a prevalent proinflammatory stimulus contributing to neurodegeneration
M Jankowska-Kieltyka, A Roman… - Frontiers in Cellular …, 2021 - frontiersin.org
Air pollution is regarded as an important risk factor for many diseases that affect a large
proportion of the human population. To date, accumulating reports have noted that …
proportion of the human population. To date, accumulating reports have noted that …
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
Background There is an unmet need to develop therapeutic interventions directed at the
neurodegeneration that underlies progression in multiple sclerosis. High-dose …
neurodegeneration that underlies progression in multiple sclerosis. High-dose …
Targeting B cells to modify MS, NMOSD, and MOGAD: part 1
Ocrelizumab, rituximab, ofatumumab, ublituximab, inebilizumab, and evobrutinib are
immunotherapies that target various B cell–related proteins. Most of these treatments have …
immunotherapies that target various B cell–related proteins. Most of these treatments have …
Positron emission tomography in multiple sclerosis—straight to the target
Following the impressive progress in the treatment of relapsing–remitting multiple sclerosis
(MS), the major challenge ahead is the development of treatments to prevent or delay the …
(MS), the major challenge ahead is the development of treatments to prevent or delay the …
Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders
Y Takai, T Misu, H Suzuki, T Takahashi, H Okada… - Brain, 2021 - academic.oup.com
Abstract Aquaporin 4 (AQP4)-IgG-positive neuromyelitis optica spectrum disorder (AQP4-
IgG+ NMOSD) is an autoimmune astrocytopathic disease pathologically characterized by …
IgG+ NMOSD) is an autoimmune astrocytopathic disease pathologically characterized by …